Document is current
Any future updates will be listed below
-
Authors
Wudhikarn, Kitsada
Bansal, Radhika https://orcid.org/0000-0003-0964-098X
Khurana, Arushi
Hathcock, Matthew A.
Bennani, N. Nora
Paludo, Jonas https://orcid.org/0000-0002-7350-5531
Villasboas, Jose C. https://orcid.org/0000-0002-2907-0809
Wang, Yucai https://orcid.org/0000-0002-1576-8341
Johnston, Patrick B.
Ansell, Stephen M.
- License Information
-
More Information
Article History
Received: 8 April 2021
Revised: 8 June 2021
Accepted: 11 June 2021
First Online: 1 July 2021
Competing interests
: K.W., A.K., R.B., M.H., J.P., J.C.V., and P.B.J. has no conflict of interest. Y.W. receives research funding from Incyte, InnoCare, Novartis, Genentech and serves on advisory board of Eli Lilly. N.N.B. served on advisory boards for Acrotech, Verastem, and Daiichi Sankyo, Inc. Y.L. provides consultation service to Kite/Gilead, Celgene/BMS, Juno/BMS, BlueBird Bio, Janssen, Legend BioTech, Gamida Cells, Novartis, Lovance, Takeda, Fosun Kite, reports received research support from Kite/Gilead, Celgene/BMS, BlueBird Bio, Janssen, Legend Biotech, Merck, Takeda and Boston Scientific and served on Drug safety monitoring board of Sorrento. All financial supports and funding are paid to Mayo clinic.
